Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation.

Cell | Dec 11, 1998

http://www.ncbi.nlm.nih.gov/pubmed/9865697

Proteins with SH2 and SH3 domains link tyrosine kinases to intracellular pathways. To investigate the biological functions of a mammalian SH2/SH3 adaptor, we have introduced a null mutation into the mouse gene for Grb2. Analysis of mutant embryonic stem cells, embryos, and chimeras reveals that Grb2 is required during embyrogenesis for the differentiation of endodermal cells and formation of the epiblast. Grb2 acts physiologically as an adaptor, since replacing the C terminus of the Ras activator Sos1 with the Grb2 SH2 domain yields a fusion protein that largely rescues the defects caused by the Grb2 mutation. Furthermore, Grb2 is rate limiting for mammary carcinomas induced by polyomavirus middle T antigen. These data provide genetic evidence for a mammalian Grb2-Ras signaling pathway, mediated by SH2/SH3 domain interactions, that has multiple functions in embryogenesis and cancer.

Pubmed ID: 9865697 RIS Download

Mesh terms: Adaptor Proteins, Signal Transducing | Animals | Antigens, Polyomavirus Transforming | Artificial Gene Fusion | Cell Differentiation | Cell Division | Cell Transformation, Neoplastic | Endoderm | Female | GRB2 Adaptor Protein | Gene Targeting | Guanine Nucleotide Exchange Factors | Humans | Male | Mammals | Mammary Neoplasms, Experimental | Mice | Proteins | ras Guanine Nucleotide Exchange Factors | ras Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.